SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-014988
Filing Date
2006-03-08
Accepted
2006-03-08 15:03:36
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-1528_110k.htm 10-K 1974202
2 MATERIAL CONTRACTS a06-1528_1ex10d32.htm EX-10.32 10754
3 SUBSIDIARIES OF THE REGISTRANT a06-1528_1ex21d1.htm EX-21.1 6562
4 CONSENTS OF EXPERTS AND COUNSEL a06-1528_1ex23d1.htm EX-23.1 3188
5 302 CERTIFICATION a06-1528_1ex31d1.htm EX-31.1 10342
6 302 CERTIFICATION a06-1528_1ex31d2.htm EX-31.2 10903
7 906 CERTIFICATION a06-1528_1ex32.htm EX-32 9265
8 GRAPHIC g15281dai001.jpg GRAPHIC 38579
  Complete submission text file 0001104659-06-014988.txt   2080002
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 06672841
SIC: 2834 Pharmaceutical Preparations